WELCOME TO MEDSHADOW. WE'VE UPDATED OUR LOOK!

Some Cancer Drugs May Boost Arthritis Risk

Arthritis Prevention: 5 Simple Hand Exercises
Arthritis Prevention: 5 Simple Hand Exercises

A class of cancer immunotherapy drugs may increase the risk of developing joint and tissue diseases, such as arthritis.

Researchers at the Johns Hopkins University School of Medicinein Baltimore  have discussed 13 case reports of patients who were taking Yervoy (ipilimumab) and/or Opdivo (nivolumab) between 2012 and this year and developed new-onset arthritis or sicca syndrome, a set of autoimmune conditions causing dry eyes and mouth, including Sjogren’s syndrome.

Yervoy and Opdivo are in a class of cancer drugs known as checkpoint inhibitors. For patients with melanoma, a type of skin cancer, the drugs are taken together. A third checkpoint inhibitor on the market is Keytruda (pembrolizumab). Opdivo and Keytruda can also be used to treat a type of lung cancer.

“In 2015, our rheumatology clinic started getting more and more referrals from our oncology department to evaluate patients treated with immunotherapies,” lead study author Laura C. Cappelli, MD, a rheumatologist at Johns Hopkins, said in a statement. “And the patients we saw had very severe, highly inflammatory arthritis. They needed even higher doses of steroids to control their symptoms compared to what is needed in other forms of inflammatory arthritis, like rheumatoid arthritis.”

However, the researchers noted that the 13 patients on checkpoint inhibitors represented only 1.5% of the patients between 2012 and 2016 who were taking one or both of the drugs at the Kimmel Cancer Center. Also, additional research is needed to determine a cause-and-effect relationship.

Cappelli said she wants the case reports, which were published in the Annals of the Rheumatic Diseases, to raise awareness among both patients and doctors of the side effects that may occur with these drugs.

“It is important when weighing the risk-benefit ratio of prescribing these drugs,” she said. “And it’s important for people to be on the lookout for symptoms so they can see a rheumatologist early in an effort to prevent or limit joint damage.”

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.

Was This Article Helpful?

Show Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x